| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:23Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang H.-Y.; Liu Y.-N.; Wu S.-G.; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; JIN-YUAN SHIH; Wang H.-Y.;Liu Y.-N.;Wu S.-G.;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Jin-Yuan Shih |
| 臺大學術典藏 |
2020-08-13T06:33:22Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
JIN-YUAN SHIH; Yu C.-J.; Liu Y.-N.; Wu S.-G.; Tsai T.-H.; Lin Y.-T.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Jin-Yuan Shih |
| 臺大學術典藏 |
2020-08-12T08:25:25Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; SHANG-GIN WU; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F. |
| 臺大學術典藏 |
2020-08-12T08:25:24Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Chen H.-Y.; Yu S.-L.; Yang J.C.-H.; Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Tsai M.-F.; Chang T.-H.; Liu Y.-N. |
| 臺大學術典藏 |
2020-08-12T08:25:23Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
SHANG-GIN WU; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Yang P.-C.; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:21Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.;Tsai M.-F.;Gow C.-H.;Shang-Gin Wu;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; SHANG-GIN WU; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:21Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer
|
Lin Y.-T.;Liu Y.-N.;Shang-Gin Wu;Yang J.C.-H.;Shih J.-Y.; Lin Y.-T.; Liu Y.-N.; SHANG-GIN WU; Yang J.C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:19Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Shang-Gin Wu;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Shih J.-Y.; SHANG-GIN WU; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:18Z |
MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process
|
Wang H.-Y.;Liu Y.-N.;Shang-Gin Wu;Hsu C.-L.;Chang T.-H.;Tsai M.-F.;Lin Y.-T.;Shih J.-Y.; Wang H.-Y.; Liu Y.-N.; SHANG-GIN WU; Hsu C.-L.; Chang T.-H.; Tsai M.-F.; Lin Y.-T.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:17Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Lin Y.-T.;Tsai T.-H.;Shang-Gin Wu;Liu Y.-N.;Yu C.-J.;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; SHANG-GIN WU; Liu Y.-N.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:10Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Chong-Jen Yu;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; Wu S.-G. |
| 臺大學術典藏 |
2020-08-12T02:50:36Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Wu C.-T.; Chang Y.-L.; Yang C.-Y.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y. |
| 臺大學術典藏 |
2020-07-21T06:46:15Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Chang Y.-L.; Su K.-Y.; Hsu C.-L.; Liu Y.-N.; Chen K.-Y.; Tsai T.-H.; Liao W.-Y.; CHAO-CHI HO; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:18Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tzu-Hsiu Tsai;Yu C.-J.;Yang J.C.-H.;Yang P.-C.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; TZU-HSIU TSAI; Yu C.-J.; Yang J.C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Shih J.-Y.; Liu Y.-N.;Chang T.-H.;Tsai M.-F.;Wu S.-G.;Tzu-Hsiu Tsai;Chen H.-Y.;Yu S.-L.;Yang J.C.-H.;Shih J.-Y.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; TZU-HSIU TSAI; Chen H.-Y.; Yu S.-L.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:25:16Z |
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer
|
Shih J.-Y.; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tzu-Hsiu Tsai;Chen P.-L.;Tsai M.-F.;Shih J.-Y.; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; TZU-HSIU TSAI; Chen P.-L.; Tsai M.-F. |
| 臺大學術典藏 |
2020-07-21T06:25:15Z |
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
|
Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tzu-Hsiu Tsai;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; TZU-HSIU TSAI; Gow C.-H.; Chang Y.-L.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:14Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
TZU-HSIU TSAI; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y.; Lin Y.-T.; Lin Y.-T.;Tzu-Hsiu Tsai;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:11Z |
Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib
|
Liu Y.-N.; Shih J.-Y.; WEI-YU LIAO; Gow C.-H. |
| 臺大學術典藏 |
2020-07-03T04:00:44Z |
The RssB/RssA two-component system regulates biosynthesis of the tripyrrole antibiotic, prodigiosin, in Serratia marcescens
|
Horng Y.-T.;Chang K.-C.;Liu Y.-N.;Hsin-Chih Lai;Soo P.-C.; Horng Y.-T.; Chang K.-C.; Liu Y.-N.; HSIN-CHIH LAI; Soo P.-C. |
| 臺大學術典藏 |
2020-07-01T08:12:19Z |
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
|
Chiu K.-L.;Lin Y.-S.;Kuo T.-T.;Lo C.-C.;Huang Y.-K.;Chang H.-F.;Chuang E.Y.;Lin C.-C.;Cheng W.-C.;Liu Y.-N.;Liang-Chuan Lai;Sher Y.-P.; Chiu K.-L.; Lin Y.-S.; Kuo T.-T.; Lo C.-C.; Huang Y.-K.; Chang H.-F.; Chuang E.Y.; Lin C.-C.; Cheng W.-C.; Liu Y.-N.; LIANG-CHUAN LAI; Sher Y.-P. |
| 臺大學術典藏 |
2020-06-30T08:09:52Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-17T03:01:31Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Sung-Liang Yu;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; SUNG-LIANG YU; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-06-16T06:38:12Z |
A psychophysical analysis on perceptual limitation of motion image artifact reduction using 120hz displays
|
Wang, Y.-T.;Liu, Y.-N.;Chien, S.-Y.;Yang, Y.-H.;Chen, Y.-L.;Yeh, S.-L.; Wang, Y.-T.; Liu, Y.-N.; Chien, S.-Y.; Yang, Y.-H.; Chen, Y.-L.; Yeh, S.-L.; SHAO-YI CHIEN |
